Host: Sarah Thomas, managing director, Deloitte Services LP
As life sciences and health care organizations return to work, or ramp up efforts to do so, it is critical to balance health, safety, and financial concerns. What are effective strategies for rebooting and recovering, even as organizations prepare for potential future outbreaks? We’ll discuss:
- Considerations for a back to work strategy, whether ramping up utilization at hospitals, restarting life sciences clinical trials and sales calls, or just reopening offices.
- Practical issues and options for balancing in-person and virtual work.
- Resumption of non-urgent care.
Meet the speakers
Sarah is the managing director of the Center for Health Solutions, part of Deloitte LLP’s Life Sciences & Health Care practice. As the leader of the Center, she drives the research agenda to inform stakeholders across the health care landscape about key trends and issues facing the industry. Sarah has more than 13 years of government experience and has deep experience in public policy, with a focus on Medicare payment policy.
Dr. Dhar is Vice Chair and US Life Sciences and Health Care (LSHC) Industry Leader for Deloitte LLP leading the overall strategic direction for the life sciences and health care practices, including audit, consulting, tax, and advisory services. He is a respected health futurist and sought-after digital disrupter. Asif helps Governments, Life Sciences and Health Care clients reinvent wellness, solve disease, address pandemics and tackle health inequities. He is also Deloitte’s Lead Partner for the Firm’s US Food and Drug Administration (FDA) relationship and responsible for all work Deloitte performs with and for the Agency. His perspectives on real world evidence, regulatory sciences, digital health, and innovation are sought by clients around the world. Asif’s passion for the LSHC industry is evident in all that he does – as a pioneering thought leader who helped establish a framework for the Future of Health, formed ConvergeHEALTH, an award winning life sciences and health care software solution, and helped frame numerous COVID-19 health-oriented reboot and recovery solutions. He advises some of the world’s most innovative companies and Governmental agencies tackling disease and public health.
Jen, a principal at Deloitte Consulting LLP, serves as Chief Innovation Officer for our Health Care practice and leads Deloitte’s Risk & Financial Advisory Health Care practice. She works to enable health care system executives to embrace disruptive transformation, helping them leverage applied innovation to design new models of clinical care and future proof their business. Jen is passionate about navigating the rapidly changing health ecosystem and creating value on the journey to health and wellness. Jen is a nationally acclaimed speaker on the topics of Future of Health and Future of Work. Integrating her experience into Deloitte’s Future of Work framework, Jen leads teams who analyze how work can be done, by whom and where the work takes place across clinical and non-clinical functions. Through this analytical modeling, she illuminates new ways of working and engaging with patients, families and across the care team. Jen is also passionate about Diversity, Equity and Inclusion initiatives and was instrumental in the creation of the Deloitte Health Equity Institute. She is the co-founder and executive sponsor of Deloitte’s Physician Leadership Academy, supporting the evolving leadership capabilities of clinician leaders in the era of the Clinical Healthcare CEO.